Issue 64, 2013

Glycan arrays containing synthetic Clostridium difficilelipoteichoic acid oligomers as tools toward a carbohydrate vaccine

Abstract

Clostridium difficile is a leading cause of severe nosocomial infections. Cell-surface carbohydrate antigens are promising vaccine candidates. Here we report the first total synthesis of oligomers of the lipoteichoic acid antigen repeating unit. Synthetic glycan microarrays revealed anti-glycan antibodies in the blood of patients that help to define epitopes for vaccine development.

Graphical abstract: Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine

Supplementary files

Article information

Article type
Communication
Submitted
12 May 2013
Accepted
17 Jun 2013
First published
18 Jun 2013

Chem. Commun., 2013,49, 7159-7161

Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine

C. E. Martin, F. Broecker, S. Eller, M. A. Oberli, C. Anish, C. L. Pereira and P. H. Seeberger, Chem. Commun., 2013, 49, 7159 DOI: 10.1039/C3CC43545H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements